RP

Rachana Panda

Active Director Director DIN 10598248
DIN 10598248 First appointment May 2024 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2024
Shareholding value •••• Premium profile

About Rachana Panda

Data last updated:

Rachana Panda is a Director at Bayer Foundation India (since 2024). The company operates in Healthcare. Bayer Foundation India reported revenue of ₹48.8 Lakh (FY 2025).

DIN 10598248
Primary Designation Director
Industry Healthcare
First Appointment 15 May 2024
Oldest Company Age 15 yrs
Largest company Bayer Foundation India · ₹48.8 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Bayer Foundation India U85191MH2011NPL220674
Director15 May 20242011₹48.8 Lakh (FY 2025)Active

Board colleagues of Rachana Panda

Directorship timeline

Open interactive timeline →
Bayer Foundation India
Premium access

Shareholding and investment profile for Rachana Panda

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rachana Panda

Rachana Panda currently holds 1 directorship: Bayer Foundation India (Director, since 15 May 2024, revenue ₹48.8 Lakh (FY 2025)).

Rachana Panda was first appointed on 15 May 2024 as Director at Bayer Foundation India.

The current boards of Rachana Panda's companies include Ashish Shashikant Gawde (Bayer Foundation India), Devesh Chandrakant Shah (Bayer Foundation India), Shailendra Kashinath Vispute (Bayer Foundation India).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available